Tsung-Han Chou1, Stanislav Tomarev2, Vittorio Porciatti1. 1. Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida, United States. 2. Retinal Ganglion Cell Biology Section, Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Abstract
PURPOSE: To characterize age-related changes of retinal ganglion cell (RGC) function, IOP, and anatomical markers of axon/glia integrity in a transgenic mouse expressing Tyr437His mutant of human myocilin protein. METHODS: Retinal ganglion cell electrical responsiveness was tested with pattern electroretinogram (PERG) in 11 transgenic mice expressing mutated myocilin at different ages over 18 months under ketamine/xylazine anesthesia. Twelve age-matched C57BL/6J mice also were tested as controls. Intraocular pressure was measured with a Tonolab tonometer. Immunohistochemistry for GFAP and neurofilament was performed on dissected optic nerve heads. RESULTS: In transgenic mice expressing mutated myocilin, the PERG amplitude progressively decreased with increasing age by approximately 50%, whereas the PERG peak latency increased by approximately 40 ms (ANOVA, P < 0.05). In contrast, PERGs of young and old control mice had similar amplitudes and peak latencies. In transgenic mice, GFAP staining was more intense and extended than in control mice, and increased with increasing age; neurofilament staining showed swollen and partially degenerated axons in old transgenic mice. The IOP of young transgenic mice was similar to that of control mice and did not significantly change with increasing age. CONCLUSIONS: Transgenic mice expressing mutated human myocilin display progressive age-related changes in RGC electrical responsiveness that are not associated with IOP elevation but are associated with marked astrogliosis and axonopathy. Our results support the view that MYOC expression in the optic nerve may impact structural, metabolic, or neurotrophic support to RGC axons, thereby influencing their susceptibility to glaucomatous damage independently of IOP. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: To characterize age-related changes of retinal ganglion cell (RGC) function, IOP, and anatomical markers of axon/glia integrity in a transgenicmouse expressing Tyr437His mutant of humanmyocilin protein. METHODS: Retinal ganglion cell electrical responsiveness was tested with pattern electroretinogram (PERG) in 11 transgenic mice expressing mutated myocilin at different ages over 18 months under ketamine/xylazine anesthesia. Twelve age-matched C57BL/6J mice also were tested as controls. Intraocular pressure was measured with a Tonolab tonometer. Immunohistochemistry for GFAP and neurofilament was performed on dissected optic nerve heads. RESULTS: In transgenic mice expressing mutated myocilin, the PERG amplitude progressively decreased with increasing age by approximately 50%, whereas the PERG peak latency increased by approximately 40 ms (ANOVA, P < 0.05). In contrast, PERGs of young and old control mice had similar amplitudes and peak latencies. In transgenic mice, GFAP staining was more intense and extended than in control mice, and increased with increasing age; neurofilament staining showed swollen and partially degenerated axons in old transgenic mice. The IOP of young transgenic mice was similar to that of control mice and did not significantly change with increasing age. CONCLUSIONS:Transgenic mice expressing mutated humanmyocilin display progressive age-related changes in RGC electrical responsiveness that are not associated with IOP elevation but are associated with marked astrogliosis and axonopathy. Our results support the view that MYOC expression in the optic nerve may impact structural, metabolic, or neurotrophic support to RGC axons, thereby influencing their susceptibility to glaucomatous damage independently of IOP. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Richard T Libby; Michael G Anderson; Iok-Hou Pang; Zachary H Robinson; Olga V Savinova; I Mihai Cosma; Amy Snow; Lawriston A Wilson; Richard S Smith; Abbot F Clark; Simon W M John Journal: Vis Neurosci Date: 2005 Sep-Oct Impact factor: 3.241
Authors: Vladimir Senatorov; Irina Malyukova; Robert Fariss; Eric F Wawrousek; Srividya Swaminathan; Shyam K Sharan; Stanislav Tomarev Journal: J Neurosci Date: 2006-11-15 Impact factor: 6.167
Authors: Allan R Shepard; Nasreen Jacobson; J Cameron Millar; Iok-Hou Pang; H Thomas Steely; Charles C Searby; Val C Sheffield; Edwin M Stone; Abbot F Clark Journal: Hum Mol Genet Date: 2007-02-22 Impact factor: 6.150
Authors: Ileana Soto; Ericka Oglesby; Brian P Buckingham; Janice L Son; Elisha D O Roberson; Michael R Steele; Denise M Inman; Monica L Vetter; Philip J Horner; Nicholas Marsh-Armstrong Journal: J Neurosci Date: 2008-01-09 Impact factor: 6.167
Authors: Michael G Anderson; Richard T Libby; Mao Mao; Ioan M Cosma; Larry A Wilson; Richard S Smith; Simon W M John Journal: BMC Biol Date: 2006-07-07 Impact factor: 7.431
Authors: Gareth R Howell; Richard T Libby; Tatjana C Jakobs; Richard S Smith; F Campbell Phalan; Joseph W Barter; Jessica M Barbay; Jeffrey K Marchant; Nagaraju Mahesh; Vittorio Porciatti; Alan V Whitmore; Richard H Masland; Simon W M John Journal: J Cell Biol Date: 2007-12-24 Impact factor: 10.539